Literature DB >> 22256811

A watershed moment in the treatment of hepatitis C.

Raymond T Chung.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22256811     DOI: 10.1056/NEJMe1113272

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Effect of discounting on estimation of benefits determined by hepatitis C treatment.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.

Authors:  Stacey B Trooskin; Joanna Poceta; Caitlin M Towey; Annajane Yolken; Jennifer S Rose; Najia L Luqman; Ta-Wanda L Preston; Philip A Chan; Curt Beckwith; Sophie C Feller; Hwajin Lee; Amy S Nunn
Journal:  J Gen Intern Med       Date:  2015-02-14       Impact factor: 5.128

3.  The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Authors:  Kaku Goto; Wenyu Lin; Leiliang Zhang; Nikolaus Jilg; Run-Xuan Shao; Esperance A K Schaefer; Hong Zhao; Dahlene N Fusco; Lee F Peng; Naoya Kato; Raymond T Chung
Journal:  J Hepatol       Date:  2013-07-02       Impact factor: 25.083

4.  Hepatitis C screening: getting it right.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2012-12-24       Impact factor: 17.425

Review 5.  Alcoholic hepatitis and concomitant hepatitis C virus infection.

Authors:  Mohamed Shoreibah; Bhupinderjit S Anand; Ashwani K Singal
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  Sofosbuvir and ABT-450: terminator of hepatitis C virus?

Authors:  Qing-Lei Zeng; Ji-Yuan Zhang; Zheng Zhang; Li-Feng Wang; Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

7.  Utility of evaluating HCV in an uninsured population.

Authors:  Indira Donepudi; Angelo Paredes; Sarah Hubbard; Chadi Awad; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2014-11-05       Impact factor: 3.199

Review 8.  Current and emerging antiviral treatments for hepatitis C infection.

Authors:  Joseph S Doyle; Esther Aspinall; Danny Liew; Alexander J Thompson; Margaret E Hellard
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

9.  A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.

Authors:  Emerson Y Chen; William M Lee; Linda S Hynan; Amit G Singal
Journal:  J Clin Gastroenterol       Date:  2013-10       Impact factor: 3.062

10.  Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response.

Authors:  Samali Lubega; Uchenna Agbim; Miranda Surjadi; Megan Mahoney; Mandana Khalili
Journal:  Liver Int       Date:  2013-03-20       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.